Hideki Tokunaga

Sendai, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 123 publications

Clinicopathological Status and Prognostic Factors of Recurrent Epithelial Ovarian Cancer in Japan: Retrospective Survey of JSOG Committee on Gynecologic Oncology.

Clinicopathological Status and Prognostic Factors of Recurrent Epithelial Ovarian Cancer in Japan: Retrospective Survey of JSOG Committee on Gynecologic Oncology.

Journal: The journal of obstetrics and gynaecology research

Published: February 09, 2026

Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis.

Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis.

Journal: International journal of clinical oncology

Published: January 20, 2026

Establishment and Operation of a New Style Clinical Biobank: The Tohoku University Clinical Biobank.

Establishment and Operation of a New Style Clinical Biobank: The Tohoku University Clinical Biobank.

Journal: The Tohoku journal of experimental medicine

Published: January 14, 2026

Trends in the management and prognosis of mucinous borderline ovarian tumors: analysis of 12,766 cases from the JSOG Gynecologic Tumor Registry (2004-2018).

Trends in the management and prognosis of mucinous borderline ovarian tumors: analysis of 12,766 cases from the JSOG Gynecologic Tumor Registry (2004-2018).

Journal: International journal of clinical oncology

Published: October 29, 2025

Survival and prognostic factors in vaginal cancer: an analysis of 2016-2020 nationwide data.

Survival and prognostic factors in vaginal cancer: an analysis of 2016-2020 nationwide data.

Journal: International journal of clinical oncology

Published: October 28, 2025

Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.

Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.

Journal: International journal of clinical oncology

Published: October 23, 2025

Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.

Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.

Journal: Journal of gynecologic oncology

Published: August 27, 2025

Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study (JORTC-KMP03).

Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study (JORTC-KMP03).

Journal: Integrative cancer therapies

Published: March 29, 2025

Treatment patterns and prognosis of vulvar cancer: a nationwide retrospective analysis from the JSOG tumor registry (2016-2020).

Treatment patterns and prognosis of vulvar cancer: a nationwide retrospective analysis from the JSOG tumor registry (2016-2020).

Journal: Journal of gynecologic oncology

Published: February 25, 2025

Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasm.

Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasm.

Journal: Journal of gynecologic oncology

Published: October 25, 2024

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Journal: Cancers

Published: October 13, 2024

Returning genetic risk information for hereditary cancers to participants in a population-based cohort study in Japan.

Returning genetic risk information for hereditary cancers to participants in a population-based cohort study in Japan.

Journal: Journal of human genetics

Published: September 14, 2024

Showing 1-12 of 123

Last Updated: 09/26/2026